Copyright
©The Author(s) 2026.
World J Gastroenterol. Jan 21, 2026; 32(3): 116350
Published online Jan 21, 2026. doi: 10.3748/wjg.v32.i3.116350
Published online Jan 21, 2026. doi: 10.3748/wjg.v32.i3.116350
Table 1 Tick species implicated in alpha-gal syndrome and their geographical distribution based on collection from available regional data
| Tick species (common/scientific) | Typical geographic distribution/reported locations | Evidence/notes |
| Lone star tick - Amblyomma americanum[7] | Southeastern, mid-Atlantic, and parts of the Midwest United States; expanding northward and westward | Principal vector implicated in most United States AGS cases and in large surveillance studies |
| Sheep/deer tick - Ixodes Ricinus[16] | Europe (Sweden, France, Germany, Spain and other temperate countries) | Reported to carry α-gal-containing antigens and linked to sensitization in European case series |
| Paralysis tick - Ixodes holocyclus[14] | Eastern Australia (coastal New South Wales, Queensland) | Identified in Australian reports as associated with α-gal sensitization and tick-bite-related meat allergy |
| Asian longhorned tick – H. longicornis[17] | East Asia (Japan, Korea), parts of China; also detected in other regions | Salivary proteins with α-gal detected; case series from Japan and case reports implicate H. longicornis in sensitization |
| Amblyomma sculptum[18] | Brazil and other parts of South America | α-gal epitopes detected in saliva; experimental/serologic data support potential for sensitization |
| Amblyomma hebraeum/Rhipicephalus spp. (Africa)[19] | Sub-Saharan Africa (limited serologic detection; data sparse) | Serologic detection of α-gal in some parasites/ticks reported, but clinical case correlation and surveillance remain limited |
| Blacklegged/deer tick - Ixodes scapularis (and other Ixodes spp.)[8] | North America (northeast, upper Midwest); occasional recent case reports linking Ixodes spp. to AGS | Emerging reports suggest other Ixodes species may rarely be associated with α-gal sensitization in addition to Amblyomma spp. |
Table 2 Comparison between alpha-gal syndrome, non-celiac gluten sensitivity and Lactose Intolerance based on their diagnostic and pathophysiologic mechanisms
| AGS | NCGS | Lactose intolerance | |
| Etiology | Mammalian products including beef, pork, lamb, venison and sometimes dairy/gelatin | Symptoms are triggered by gluten | Digestive problem caused by deficiency of the lactase enzyme |
| Onset | Delayed (typically 2-6 hours after eating the trigger food) | Within hours after consuming gluten | Within hours after dairy ingestion |
| Symptom manifestation | Hives, itching, swelling, nausea, vomiting, abdominal pain and diarrhea. Can potentially manifest as anaphylaxis | Abdominal pain, bloating, diarrhea, fatigue and headache | Nausea, bloating, abdominal cramps, gas and diarrhea |
| Immune mechanism | Allergic (type 1 hypersensitivity reaction) | Innate immune system | Digestive disorder involving lack of lactase enzyme |
| Diagnosis | Blood test for alpha-gal-specific IgE antibodies | Clinical diagnosis made by excluding celiac disease and wheat allergy but involving a positive response to gluten-free diet | Hydrogen Breath test and Lactose intolerance test |
Table 3 Multiple organ-systems affected by alpha-gal syndrome and associated symptom manifestation[35]
| Organ system | Common signs & symptoms | Approximately of patients affected (%) |
| Cutaneous/skin | Urticaria (hives), pruritus, angioedema (lips, eyelids, tongue, throat) | 56-80 |
| GI | Abdominal pain, nausea, vomiting, diarrhea, bloating | 47-69 |
| Respiratory | Wheezing, cough, shortness of breath, nasal congestion | 15-30 |
| Cardiovascular | Hypotension, dizziness, syncope (especially in anaphylaxis) | 10-25 |
| Systemic/anaphylaxis | Multisystem involvement (≥ 2 organ systems), generalized reactions | 50-75 |
Table 4 Clinical pearl summarizing alpha-gal syndrome for clinical practice, estimates may vary based on clinical presentation
| Step | Action | Key decision-points/notes |
| Clinical suspicion[30,42] | Obtain detailed patient history (tick exposure, delay after mammalian meat ingestion, GI or allergic symptoms) | A high index of suspicion is required, especially in tickendemic regions or unexplained GI symptoms |
| Note typical timeline: Ingestion of mammalian (non-primate) meat/products → delayed onset (approximately 2-6 hours) of symptoms (skin, GI, respiratory, cardiovascular) | ||
| Initial evaluation[41] | Physical exam (skin, airway, vital signs) | Because AGS can mimic other GI/food-allergy conditions, exclusion of more common diagnoses is prudent |
| Consider other causes of symptoms (food intolerance, NCGS, lactose intolerance, IBS, conventional meat allergy) | ||
| Laboratory testing[40] | Order serum IgE specific to galactose-α-1,3-galactose (α-gal sIgE) | Typical cutoffs vary; e.g., > 0.1 kUA/L often used, but not strictly diagnostic of clinical allergy |
| Understand that a positive test alone does not confirm AGS - must correlate with history and symptoms | ||
| Correlation of history + test + response[29] | Confirm delayed reaction after mammalian meat ingestion and positive α-gal sIgE | This triad (history + lab + diet response) is often used in practice to establish diagnosis |
| Evaluate response to elimination of mammalian meat/products (clinical improvement) | ||
| Further evaluation/referral | If test is negative but suspicion remains high: Consider referral to allergist for intradermal testing, basophil activation test, or supervised food challenge (in experienced center) | Food challenge in AGS requires caution due to delayed onset and potential severity |
| If significant allergic/anaphylactic signs (multisystem involvement) → allergy/immunology referral | ||
| Diagnosis and management plan[30,40] | If AGS is confirmed: Counsel on avoidance of mammalian meat/products (and possibly mammalianderived medications/biologics) | Although not strictly part of diagnostic algorithm, management planning is integral once the diagnosis is made |
| Educate on tickbite prevention (to avoid further sensitization) | ||
| Arrange appropriate follow-up and monitoring (including reconsidering re-introduction under guidance if IgE levels decline) |
- Citation: Awosika A, Balaji P. Misdiagnosis of alpha-gal syndrome as non-celiac gluten sensitivity or lactose intolerance: A diagnostic blind spot for clinicians. World J Gastroenterol 2026; 32(3): 116350
- URL: https://www.wjgnet.com/1007-9327/full/v32/i3/116350.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i3.116350
